Note: Ingredients listed on restricted chemical lists
EC/CAS
205-592-6/143-22-6
Name of the chemical
2-(2-(2-butoxyethoxy)ethoxy)ethanol
Concentration
≥10
EC/CAS
203-872-2/111-46-6
Name of the chemical
diethyleneglycol
Concentration
<10
EC/CAS
203-961-6/112-34-5
Name of the chemical
2-(2-butoxyethoxy)ethanol
Concentration
<5
EC/CAS
203-906-6/111-77-3
Name of the chemical
2-(2-methoxyethoxy)-ethanol
Concentration
<5
General Information
Version
1.0
Revision date
2023-06-16
Product name
Brake Fluid DOT 4
supplier name
Morris Lubricants
Emergency telephone
+44 (0) 1743 232200
Icons in SDS
Company Information
company name
Morris Lubricants
e-mail address of the competent person responsible for the Safety Data Sheet
sds@morris-lubricants.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H361d
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Suspected of damaging fertility or the unborn child. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
Tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl] orthoborate
Hazard statements
H319 - Causes serious eye irritation. H361d - Suspected of damaging the unborn child.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P264 - Wash hands thoroughly after handling. P301+P310 - IF SWALLOWED: Immediately call a doctor, a POISON CENTER. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents and container to an approved waste disposal plant.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %